Joanne Lundy

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Michael Friedländer, Tarek Meniawy, Ben Markman et al. · The Lancet Oncology · 2019 · 113 citations

Medicine, Pharmacology, Advanced Solid Tumours +6

Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma

Loryn Holokai, Jayati Chakrabarti, Joanne Lundy et al. · Cancers · 2020 · 97 citations · Full text

KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?

Henry Shen, Joanne Lundy, Andrew Strickland et al. · Cells · 2022 · 49 citations · Full text

A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

Michael Friedländer, Tarek Meniawy, Ben Markman et al. · Journal of Clinical Oncology · 2018 · 33 citations

Immunology, Immunoediting, Immunotherapeutics +17

Pulmonary metastases, a potential biologic consequence of anesthetic-induced immunosuppression by thiopental.

Joanne Lundy, Lovett Ej, Philip B. Conran · PubMed · 1977 · 28 citations